This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Document and Entity Information
Financial Statements
Consolidated Statements of Operations and Other Comprehensive Income (Loss)
Consolidated Statements of Financial Position
Consolidated Statements of Changes in Shareholders' Equity
Consolidated Statements of Cash Flows
Notes to Financial Statements
Corporate Information
Significant accounting policies
Notes to the consolidated financial statements
Fixed Assets
Inventories
Other financial assets
Prepaid expenses and other current assets
Equity
Share-based payments
Trade and other payables
Other liabilities
Loans
Income tax
Earnings per share
Disclosure of financial instruments and management of financial risks
Notes to the consolidated statements of cash flows
Commitments and contingencies
Remuneration of the Company's key management personnel
Other related party disclosures
Subsequent events
Accounting Policies
Significant accounting policies (Policies)
Notes Tables
Significant accounting policies (Tables)
Notes to the consolidated financial statements (Tables)
Fixed Assets (Tables)
Inventories (Tables)
Other financial assets (Tables)
Equity (Tables)
Share-based payments (Tables)
Trade and other payables (Tables)
Other liabilities (Tables)
Income tax (Tables)
Disclosure of financial instruments and management of financial risks (Tables)
Notes to the consolidated statements of cash flows (Tables)
Remuneration of the Company's key management personnel (Tables)
Notes Details
Corporate Information (Details)
Significant accounting policies - Additional Information (Details)
Significant accounting policies - Estimated useful lives Intangible assets (Details)
Significant accounting policies - Property, plant and equipment (Details)
Significant accounting policies - Estimated useful life of right-of-use assets (Details)
Notes to the consolidated financial statements - Revenue from contract with customers (Details)
Notes to the consolidated financial statements - Summary of upfront payments and related revenues recognized (Details)
Notes to the consolidated financial statements - Contract liabilities allocated to the remaining performance obligations (Details)
Notes to the consolidated financial statements - Contract liabilities allocated to the remaining performance obligations (Details)
Notes to the consolidated financial statements - Cost of sales (Details)
Notes to the consolidated financial statements - Selling and distribution expenses (Details)
Notes to the consolidated financial statements - Research and development expenses (Details)
Notes to the consolidated financial statements - General and administrative expenses (Details)
Notes to the consolidated financial statements - Other operating income (Details)
Notes to the consolidated financial statements - Grants with government agencies and similar bodies (Details)
Notes to the consolidated financial statements - Other operating expenses (Details)
Fixed Assets - Intangible assets (Details)
Fixed Assets - Property, plant and equipment (Details)
Fixed Assets - Carrying amounts of right-of-use (Details)
Fixed Assets - Carrying amounts of lease liabilities (Details)
Fixed Assets - Amounts recognized in the statement of operations (Details)
Fixed Assets - Non-current other assets (Details)
Inventories (Details)
Other financial assets (Details)
Prepaid expenses and other current assets (Details)
Equity - Overview and General Remarks (Details)
Equity - Impact of share split (Details)
Equity - Genmab Investment (Details)
Equity - Private placement 2020 (Details)
Equity - Initial Public Offering and Private Placement (Details)
Equity - Exercises of share options by the former CEO (Details)
Share-based payments - Management share option plans (Details)
Share-based payments - Virtual shares program I (Details)
Share-based payments - Virtual shares program I - Development of the virtual shares in this program granted to management and key employees (Details)
Share-based payments - Virtual shares program I - (Expense) / benefit recognized in the statement of operations and other comprehensive income (loss) (Details)
Share-based payments - Virtual shares program II (New VSOP) (Details)
Share-based payments - Virtual shares program II (New VSOP) - inputs used in the measurement of the fair value at grant date (Details)
Share-based payments - Virtual shares program II (New VSOP) - Reconciliation of outstanding awards (Details)
Share-based payments - Virtual shares program II (New VSOP) - Expense recognized in the statement of operations and other comprehensive income (loss) (Details)
Share-based payments - Former Chief Executive Officer Grant (Details)
Share-based payments - Former Chief Executive Officer Grant - Long-Term Incentive Plan (LTIP) (Details)
Share-based payments - Former Chief Executive Officer Grant - Long-Term Incentive Plan (LTIP) - inputs used in the measurement of the fair value at grant date (Details)
Share-based payments - Former Chief Executive Officer Grant - Expense recognized in the statement of operations and other comprehensive income (loss) (Details) -New
Share-based payments - Former Chief Executive Officer Grant - Reconciliation of outstanding awards (Details)
Share-based payments - Former Chief Executive Officer Grant - Long-Term Incentive Plan (LTIP) (Details)
Share-based payments - Former Chief Executive Officer Grant - Grant to former chief executive officer (Details)
Share-based payments - Former Chief Executive Officer Grant - inputs used in the measurement of the fair value at grant date (Details)
Share-based payments - Former Chief Executive Officer Grant - Legacy plan (Details)
Trade and other payables (Details)
Other liabilities (Details)
Loans (Details)
Loans - Financing arrangement with the European investment Bank (Details)
Income tax (Details)
Income tax - Schedule of tax reconciliation (Details)
Income tax - Schedule of deferred taxes (Details)
Income tax - Schedule of unused tax losses carried forward (Details)
Income tax - Schedule of Deductible temporary differences (Details)
Earnings per share (Details)
Disclosure of financial instruments and management of financial risks (Details)
Disclosure of financial instruments and management of financial risks - Financial Liabilities, Commitments According (Details)
Disclosure of financial instruments and management of financial risks - Foreign currency risk (Details)
Disclosure of financial instruments and management of financial risks - Additional information (Details)
Notes to the consolidated statements of cash flows - Financing activities (Details)
Remuneration of the Company's key management personnel (Details)
Other related party disclosures (Details)
Subsequent events (Details)
Subsequent events - GSK (Details)
All Reports